Gabriel Martello
Rheumatology · Sun City Center, FLNPI 1780211904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 291 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.
Across 291 payments — averaging $30.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sanofi$2K
- Amgen$1K
- Johnson & Johnson$777
- GSK$681
- Pfizer$524
- plus $2K from 26 others
What the payments were for
- Food & beverage$8,53297%
- Education$2273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,853 |
| Sanofi | 13 | $1,743 |
| Amgen(2 entities) | 59 | $1,459 |
| Johnson & Johnson(2 entities) | 27 | $777 |
| GSK | 27 | $681 |
| Pfizer | 29 | $524 |
| Janssen Scientific Affairs, LLC | 2 | $242 |
| UCB, Inc. | 16 | $234 |
| AstraZeneca | 7 | $176 |
| Novartis | 8 | $154 |
| Boehringer Ingelheim | 6 | $145 |
| Gilead | 1 | $124 |
| Fresenius Kabi USA, LLC | 5 | $98 |
| Lilly USA, LLC | 2 | $86 |
| Novo Nordisk | 4 | $69 |
| Organon | 2 | $43 |
| Bayer | 2 | $40 |
| Sobi, Inc | 2 | $29 |
| Pharming Healthcare, Inc. | 1 | $28 |
| Radius Health, Inc. | 1 | $27 |
| Medtronic | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Aurinia Pharma U.S., Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Alvogen Inc | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,759 in reported general payments places this provider in the 55th percentile of 453 rheumatology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 53 | $3,973 |
| MethotrexateMethotrexate Sodium | 66 | $2,148 |
| Hydroxychloroquine Sulfate | 38 | $1,192 |
| Tramadol Hcl | 15 | $443 |
| Prednisone | 53 | $328 |
| Methylprednisolone | 21 | $187 |
| Gabapentin | 11 | $103 |
| Pregabalin | 13 | $91 |
| Folic Acid | 11 | $76 |
| Meloxicam | 36 | $68 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Sun City Center
- Alvin WellsDestin$2.4M
- Guillermo ValenzuelaPlantation$1.5M
- Julio Gonzalez-PaoliTampa$1.4M
- Ernesto RodriguezZephyrhills$958K
- Vinicius Costa Diniz DominguesDaytona Beach$921K
- Jonathan GreerBoynton Beach$757K
- Jigar ShahMargate$750K
- Rachel TateHollywood$729K
- Howard BuschLoxahatchee$717K
- Michael WeitzMiami$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.